Glioblastoma stem cell cultures, shifted for 15 days in serum-containing medium, undergo astrocytic and/or neural differentiation (i.e., increased expression of GFAP and MAP-2, Figure 1C) representing an in vitro model of the bulk of heterogeneous non-stem cells in GBM mass. The gene discussed is MAP2; the disease is glioblastoma.